CareLit · DOI-Nachweis · Pneumologie
Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)*
DOI 10.1055/s-0039-3403183
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Kreuter, KB Highland, M Kuwana, A Azuma, T Maher, MD Mayes, G Raghu, M Girard, V Kohlbrenner, E Clerisme-Beaty, M Alves, O Distler
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74
Kernaussage aus der Literatur
Abstract-Vorschau
Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)*
Zitieren
Zitierempfehlung
M Kreuter, KB Highland, M Kuwana, A Azuma, T Maher, MD Mayes, G Raghu, M Girard, V Kohlbrenner, E Clerisme-Beaty, M Alves, O Distler (2020) Dose adjustments in the SENSCIS Trial of nintedanib in patients with systemic sclerosis-associated ILD (SSc-ILD)*. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403183
Mit CareLit weiterarbeiten